Urinary Urge Incontinence (UUI)
0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AxonicsCA - Irvine
2 programsAxonics SNM SystemN/A1 trial
Axonics SNM System INS Model 5101N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
2031
AxonicsAxonics SNM System INS Model 5101
AxonicsAxonics SNM System
Clinical Trials (2)
Total enrollment: 199 patients across 2 trials
PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
Start: Sep 2025Est. completion: Oct 203155 patients
N/ARecruiting
F15 Recharge Free Axonics SNM System Clinical Study
Start: Dec 2023Est. completion: Dec 2027144 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 199 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.